Rinatabart sesutecan (Rina-S) demonstrated a 100% disease control rate at the 100-mg/m 2 dose for patients with heavily pretreated endometrial cancer, according to Elizabeth Lee, MD.
Alright, let’s talk about cancer, the word nobody wants to hear but one that’s important to understand. Ever wondered how cancer actually begins and what makes some people more at risk than others?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results